Bacterial Infections  >>  Besivance (besifloxacin ophthalmic suspension)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Besivance (besifloxacin ophthalmic suspension) / Bausch Health
NCT00407589: Systemic Pharmacokinetics of BOL-303224-A

Completed
1
24
US
BOL-303224-A, ISV-403, Besifloxacin
Bausch & Lomb Incorporated
Conjunctivitis, Bacterial
10/07
10/07

Download Options